Godavari Drugs, a company in the Pharmaceuticals industry, reported revenue of ₹28 crore and net profit of ₹0.96 crore for the September 2026 quarter.
Godavari Drugs (BSE: GODAVARI) closed at ₹118.95 on 20 Nov 2026, up 50.3% over the past year. Its market capitalisation is ₹130 crore and it trades at 33.7 times earnings.
Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.